Paper3045351
Minimal contact treatment for smoking cessation. A placebo controlled trial of nicotine polacrilex and self-directed relapse prevention: initial results of the Stanford Stop Smoking Project.
Fortmann SP and 3 others. JAMA, 1988. Cited by 56 papers, by iCite.
Cite this record
ConductScience Library. Minimal contact treatment for smoking cessation. A placebo controlled trial of nicotine polacrilex and self-directed relapse prevention: initial results of the Stanford Stop Smoking Project. Papers, record 3045351. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3045351
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Minimal contact treatment for smoking cessation. A placebo controlled trial of nicotine polacrilex and self-directed relapse prevention: initial results of the Stanford Stop Smoking Project.
- PubMed
- Publication types
- Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics24
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Nicotine | Major topic |
| Polymethacrylic Acids | Major topic |
| Polyvinyls | Major topic |
| Smoking | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Behavior Therapy | |
| California | |
| Carbon Monoxide | |
| Chewing Gum | |
| Clinical Trials as Topic | |
| Combined Modality Therapy | |
| Counseling | |
| Double-Blind Method | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Male | |
| Middle Aged | |
| Random Allocation | |
| Smoking Prevention | |
| Thiocyanates | |
| Tobacco Use Cessation Devices |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 5 RO1 CA38303 | NCI NIH HHS | United States | R01CA038303 | PubMed and NIH |
Source NIH RePORTER
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 56 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40390493 | Genome-wide association study -Driven drug repositioning for the treatment of insomnia. | J Genet Eng Biotechnol | 2025 | https://conductscience.org/library/papers/40390493 | PubMed |
| 37335995 | Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. | Cochrane Database Syst Rev | 2023 | https://conductscience.org/library/papers/37335995 | PubMed |
| 34611902 | Interventions for preventing weight gain after smoking cessation. | Cochrane Database Syst Rev | 2021 | https://conductscience.org/library/papers/34611902 | PubMed |
| 30997928 | Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. | Cochrane Database Syst Rev | 2019 | https://conductscience.org/library/papers/30997928 | PubMed |
| 30623970 | Print-based self-help interventions for smoking cessation. | Cochrane Database Syst Rev | 2019 | https://conductscience.org/library/papers/30623970 | PubMed |
| 29852054 | Nicotine replacement therapy versus control for smoking cessation. | Cochrane Database Syst Rev | 2018 | https://conductscience.org/library/papers/29852054 | PubMed |
| 21142259 | Adverse effects and tolerability of medications for the treatment of tobacco use and dependence. | Drugs | 2010 | https://conductscience.org/library/papers/21142259 | PubMed |
| 20626883 | Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation. A systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individuals. | Tob Induc Dis | 2010 | https://conductscience.org/library/papers/20626883 | PubMed |
| 20495885 | Predictors of adherence to nicotine gum and counseling among African-American light smokers. | J Gen Intern Med | 2010 | https://conductscience.org/library/papers/20495885 | PubMed |
| 20091554 | Placebo interventions for all clinical conditions. | Cochrane Database Syst Rev | 2010 | https://conductscience.org/library/papers/20091554 | PubMed |
| 19761618 | Efficacy of pharmacotherapies for short-term smoking abstinance: a systematic review and meta-analysis. | Harm Reduct J | 2009 | https://conductscience.org/library/papers/19761618 | PubMed |
| 18625984 | Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials. | CMAJ | 2008 | https://conductscience.org/library/papers/18625984 | PubMed |
| 18425675 | Integrating individual and public health perspectives for treatment of tobacco dependence under managed health care: a combined stepped-care and matching model. | Ann Behav Med | 1996 | https://conductscience.org/library/papers/18425675 | PubMed |
| 1796127 | Prospective study of factors influencing the development of craving associated with smoking cessation. | Psychopharmacology (Berl) | 1991 | https://conductscience.org/library/papers/1796127 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3045351
GET https://conductscience.org/api/papers/v1/3045351/authors